Table Graph
      published meta-analysis   sensitivity analysis   studies

placebo in COVID 19 outpatients - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsPINETREE (GS-US-540-9012), 2021 (REV) 0.99 [0.02; 49.86] 0.99[0.02; 49.86]PINETREE (GS-US-540-9012), 2021 (REV)10%562NAnot evaluable deathsdetailed resultsPINETREE (GS-US-540-9012), 2021 (REV) 0.99 [0.02; 49.86] 0.99[0.02; 49.86]PINETREE (GS-US-540-9012), 2021 (REV)10%562NAnot evaluable hospitalization or deathdetailed resultsPINETREE (GS-US-540-9012), 2021 (REV) 7.69 [1.73; 34.11] 7.69[1.73; 34.11]PINETREE (GS-US-540-9012), 2021 (REV)10%562NAnot evaluable hospitalizationdetailed resultsPINETREE (GS-US-540-9012), 2021 (REV) 3.57 [1.30; 9.78] 3.57[1.30; 9.78]PINETREE (GS-US-540-9012), 2021 (REV)10%562NAnot evaluable AE leading to drug discontinuationdetailed resultsPINETREE (GS-US-540-9012), 2021 (REV) 2.49 [0.48; 12.95] 2.49[0.48; 12.95]PINETREE (GS-US-540-9012), 2021 (REV)10%562NAnot evaluable serious adverse eventsdetailed resultsPINETREE (GS-US-540-9012), 2021 (REV) 3.94 [1.45; 10.72] 3.94[1.45; 10.72]PINETREE (GS-US-540-9012), 2021 (REV)10%562NAnot evaluable adverse eventsdetailed resultsPINETREE (GS-US-540-9012), 2021 (REV) 1.18 [0.84; 1.64] 1.18[0.84; 1.64]PINETREE (GS-US-540-9012), 2021 (REV)10%562NAnot evaluable0.520.01.0relative treatment effectwww.metaEvidence.org2024-08-11 16:16 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 97 - treatments: 650 - roots T: 650

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons